Overview
Japanese Phase 1 Multiple Ascending Dose (MAD) Study
Status:
Completed
Completed
Trial end date:
2012-05-01
2012-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this clinical study is to assess the safety and tolerability of multiple oral doses of BMS-820836 in healthy Japanese subjects and Japanese patients with depression.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Bristol-Myers Squibb
Criteria
Inclusion Criteria:- Healthy Japanese subjects and Japanese patients with depression (Hamilton Rating Scale
for Depression (HAM-D) ≥ 14), ages 20 to 55 years.
Exclusion Criteria:
- Any significant acute or chronic medical illness.
- Non-compliance, or overall not suitable as determined by the investigator.
- History of, or current clinically significant psychiatric disorders or illnesses,
substance abuse or dependence.